menu
    • menu

    Company profile for Rise Therapeutics

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Rise Therapeutics, we develop targeted immunological-based biologics using a unique and proprietary oral delivery platform. We design and produce unique, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity, infection, and cancer. Rise Therapeutics is built on the foundation that life-changing products are developed through key values that drive us as individuals in our personal and profess...
    At Rise Therapeutics, we develop targeted immunological-based biologics using a unique and proprietary oral delivery platform. We design and produce unique, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity, infection, and cancer. Rise Therapeutics is built on the foundation that life-changing products are developed through key values that drive us as individuals in our personal and professional life.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rise TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1405 Research Blvd., Suite 220 Rockville, MD 20850
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://risetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rise-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rise Therapeutics Secures Funding To Advance R-2487 Biomodulator
    Rise Therapeutics Secures Funding To Advance R-2487 Biomodulator

    23 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rise-therapeutics-secures-new-funding-to-advance-first-in-class-r-2487-oral-immune-biomodulator-into-sjogrens-disease-clinical-testing-302563614.html

    PR NEWSWIRE
    23 Sep 2025
    Share Share
    Rise Therapeutics Reports UC Dose Escalation Results at DDW Conf
    Rise Therapeutics Reports UC Dose Escalation Results at DDW Conf

    07 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rise-therapeutics-reports-ulcerative-colitis-dose-escalation-clinical-results-for-r-3750-at-the-digestive-disease-week-ddw-conference-in-san-diego-may-3-6-302421697.html

    PR NEWSWIRE
    07 Apr 2025
    Share Share
    Rise Therapeutics Gets FDA IND Clearance For R-5780 Cancer Testing
    Rise Therapeutics Gets FDA IND Clearance For R-5780 Cancer Testing

    13 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rise-therapeutics-receives-fda-ind-clearance-to-initiate-clinical-testing-of-r-5780-in-cancer-302349316.html

    PR NEWSWIRE
    13 Jan 2025
    Share Share
    Dose Escalation done for Rise Therapeutic R-3750 & R-2487 Trials
    Dose Escalation done for Rise Therapeutic R-3750 & R-2487 Trials

    06 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dose-escalation-completed-for-rise-therapeutics-r-3750-and-r-2487-clinical-trials-302343213.html

    PR NEWSWIRE
    06 Jan 2025
    Share Share
    ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
    ReCerise Therapeutics Inc. Selected for Government Project by MOTIE

    01 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240630932394/en

    BUSINESSWIRE
    01 Jul 2024
    Share Share
    First Patient Enrolled in Rise Therapeutics' Rheumatoid Arthritis Clinical Trial
    First Patient Enrolled in Rise Therapeutics' Rheumatoid Arthritis Clinical Trial

    29 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-patient-enrolled-in-rise-therapeutics-rheumatoid-arthritis-clinical-trial-302045960.html

    PR NEWSWIRE
    29 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search